P473: DEVELOPMENT OF POTENTIAL BIOMARKERS FOR IRAK4 INHIBITOR EMAVUSERTIB IN HUMAN ACUTE MYELOID LEUKEMIA. (23rd June 2022) - Ugolkov, A.; Pilichowska, M.; Li, C.-C.; Hok, R. C.; Samson, M.; Lane, M.; Von Roemeling, R.; Martell, R.